Document is current
Any future updates will be listed below
-
Authors
Englert, Joshua A. https://orcid.org/0000-0002-1257-2239
Cho, Michael H.
Lamb, Andrew E.
Shumyatcher, Maya
Barragan-Bradford, Diana
Basil, Maria C.
Higuera, Angelica
Isabelle, Colleen
Vera, Mayra Pinilla
Dieffenbach, Paul B.
Fredenburgh, Laura E.
Kang, Joyce B.
Bhatt, Ami S.
Antin, Joseph H.
Ho, Vincent T.
Soiffer, Robert J.
Howrylak, Judie A.
Himes, Blanca E.
Baron, Rebecca M.
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (K08 GM102695)
National Heart, Lung, and Blood Institute (R56 HL142767, R01 HL135142, R01 HL141992, R01 HL133433, R01 HL112747)
GlaxoSmithKline
Marhsall Neilson Fund for GVHD Research
- License Information
-
More Information
Article History
Received: 27 July 2018
Accepted: 8 January 2019
First Online: 21 January 2019
Ethics approval and consent to participate
: The samples used for this study were obtained from the Registry of Critical Illness which is an IRB approved biorepository at Brigham and Women’s Hospital. Consent is obtained from each subject or their legally authorized representative at the time of enrollment. The Partners Healthcare Human Research Committee originally provided initial approval in June 2008 and the protocol was most recently approved in October 2017 (Protocol number 2008P000495).
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
